Position history for MORGAN STANLEY's holdings in Inhibrx Biosciences, Inc.
MORGAN STANLEY holds 1.2M shares of INBX (Inhibrx Biosciences, Inc.), worth $92.3M as of 2025-Q4. The position was increased (++163.7% shares). INBX represents 0.0% of MORGAN STANLEY's portfolio.
Current Value
$92.3M
Current Shares
1.2M
Total Value Change
+$88.9M
Total Shares Change
+931,812
Other major holders of INBX: VIKING GLOBAL INVESTORS LP, HighTower Advisors, LLC, BlackRock, Inc., VANGUARD GROUP INC
Increased |
| 1.2M |
+163.7% |
| $92.3M |
| 0.0% |
| $77.98 |
48 |
| 2025-Q3 | Increased | 442,856 | +1492.5% | $14.9M | 0.0% | $32.31 | 45 |
| 2025-Q2 | Decreased | 27,808 | -24.6% | $396,821 | 0.0% | $14.43 | 0 |
| 2025-Q1 | Decreased | 36,900 | -7.1% | $516,230 | 0.0% | $14.12 | 0 |
| 2024-Q4 | Decreased | 39,715 | -83.4% | $611,612 | 0.0% | $15.14 | 0 |
| 2024-Q3 | Increased | 239,240 | +1.4% | $3.7M | 0.0% | $15.52 | 27 |
| 2024-Q2 | New | 235,916 | - | $3.3M | 0.0% | $14.17 | 37 |